Table 2 ChIP-seq and DNase-seq data summary
From: Predicting double-strand DNA breaks using epigenome marks or DNA at kilobase resolution
Cell line | Treatment | Technique | Number of replicates | Accession |
|---|---|---|---|---|
NHEK | No treatment | CTCF, H3K4me3, H3K27me3, H3K36me3 ChIP-seq | 2 | ENCODE uniform peaks |
NHEK | No treatment | EZH2, H3K4me1/me2, H3K9me1/me3/ac, H3K79me2, H4K20me1, H2A.Z, H3K27ac, POL2B ChIP-seq | 1 | ENCODE uniform peaks |
NHEK | No treatment | DNase-seq | 2 | ENCODE uniform peaks |
NHEK | No treatment | p63 ChIP-seq | 1 | GSE59827 |
U2OS | No treatment | DNase-seq, H3K27ac ChIP-seq | 1 | GSE87831 |
U2OS | No treatment | H3K4me1, POL2B ChIP-seq | 1 | GSE73742 |
U2OS | No treatment | H3K4me3, H3K27me3 ChIP-seq | 1 | GSE35573 |
U2OS | No treatment | H3K9me3, H3K36me3 ChIP-seq | 1 | ENCODE |
U2OS | No treatment | CTCF ChIP-seq | 1 | ChIP-Atlas |
U2OS | 4-hydroxytamoxifen | XRCC4, γ-H2A.X ChIP-seq | 1 | E-MTAB-1241 |
KBM7 | No treatment | DNase-seq | 1 | ChIP-Atlas |
KBM7 | No treatment | H3K9me3 ChIP-seq | 1 | GSE60056 |
K562 | No treatment | CTCF, H3K4me1/me3 ChIP-seq | 1 | ENCODE |
MCF-7 | No treatment | H3K4me1/me3, H3K9ac/me3, H3K27me3 ChIP-seq | 1 | GSE23701 |
MCF-7 | No treatment | DNase-seq and CTCF ChIP-seq | 1 | ENCODE |